Anonymous
Guest
Anonymous
Guest
No, but I do know what BS called it at our annual meeting.
and you believed that? we'll see. He is on the way out anyway. He's looking around.
No, but I do know what BS called it at our annual meeting.
and you believed that? we'll see. He is on the way out anyway. He's looking around.
If this test did what RK PHD claims it does shouldn't this be a slam dunk success by now--seven years right? Why hasn't some savvy business bought this product? Maybe new sales people will make the difference, to steal a phrase from when the same era this was conceived.
That's the ticket.
Press release? that's the CEO's trick. try the website as well. My things have changed. I guess stagnant sales will do that.
ImmuKnow is a biomarker of immune function that complements immunomodulatory therapy and helps physicians and other healthcare professionals more effectively manage immunosuppression in posttransplant patients, thereby reducing the risks of infection and rejection by:
Providing a global marker of immune function and response to immunosuppression at the cellular level Detecting changes in CD4 cell ATP production Helping to define a range of stable immune function for each patient Providing critical, actionable information on an ongoing, individual basis when used longitudinally (in combination with other routine monitoring tests)
ImmuKnow is the FDA-cleared assay that tracks changes in global immune function over time.
Hmm that is not what the intended use statement says. So mr compliance officer what say you? or mr govt?
How many more centers are going to stop using? Might as well move operations to Europe or sell teh company to Sigma Tau. Mr Stewart should have an in there. Where is doug Brown and does anyone care?
look please get off our board. it is very simple really. you have a product that is measuring something else besides what the IFU says. you have an organization led by an egomaniac that doesn't have a clue or want s to know about transplantation. you have a sales force that was decimated by the CFO that isnt here anymore and a sales guy that is two managers ago. big centers have jumped ship so selling effort is focusing on international markets. so the only way to communicate what you cant say is through press releases and the web. the ceo is a hypocrite and now knows what needs to be said to even have a chance of people using the product.
All you need to know is to look at the sales team that was - EN; CB; CD; AP; PM; RF; KE; JP; that was a pretty good group that was left alone to sell - wonder why they all left? DB and BS
All you need to know is to look at the sales team that was - EN; CB; CD; AP; PM; RF; KE; JP; that was a pretty good group that was left alone to sell - wonder why they all left? DB and BS
You're right, that was a good group. The biggest mistake the company made was letting go of Petruny. Good guy who knew the TX market.
Are they still stuck in the $7m sales figures? The original investors in this company about 8-10 years ago have got to be chalking this up as a loss. Unless of course, some company with too much money laying around decides to buy it and we can all cash in our worthless options! Please!
Thanks for illuminating us with your response.
ImmuKnow is a biomarker of immune function that complements immunomodulatory therapy and helps physicians and other healthcare professionals more effectively manage immunosuppression in posttransplant patients, thereby reducing the risks of infection and rejection by:
Providing a global marker of immune function and response to immunosuppression at the cellular level Detecting changes in CD4 cell ATP production Helping to define a range of stable immune function for each patient Providing critical, actionable information on an ongoing, individual basis when used longitudinally (in combination with other routine monitoring tests)
ImmuKnow is the FDA-cleared assay that tracks changes in global immune function over time.
What is the story on our Business Director -- JO ?
Was he a good mgr at Abbott ?
All true. Also, what happened to GN our rep in Nashville ?
Is he still here ?
What do you think about our new " Sales Director " ?